GRF
Eagle Capital Growth Fund, Inc.
NYSE MKT
People also watch:GLVCETEQSGLUASG
7.93-0.02 (-0.22%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close7.95
Open7.95
Bid7.91 x 100
Ask7.99 x 200
52wk Range6.41 - 10.20
Day's Range7.93 - 7.96
Volume5,814
Avg Vol (3m)5,587
As of 4:00 PM EDT. Market closed.
  • Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016
    Capital Cube6 days ago

    Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016

    Click here to see latest analysisGreiffenberger AG reports financial results for the half-year ended December 31, 2015.HighlightsSummary numbers: Revenues of EUR 77.30 million, Net Earnings of EUR -25.15 million.Gross margins narrowed from 13.81% to -5.84% compared to the same period last year, operating (EBITDA) margins now 1.20% from 3.35%.Change in operating cash flow of -191.27% […] (Read more...) The post Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016 appeared first on CapitalCube.

  • Grifols SA : Neutral outlook but great fundamentals
    Capital Cube15 days ago

    Grifols SA : Neutral outlook but great fundamentals

    Grifols SA relative valuation is now NEUTRAL. It was previously rated UNDERVALUED, and has a fundamental analysis score of 66.Our analysis is based on comparing Grifols SA with the following peers – Baxter International Inc., AB Biotics S.A., Almirall SA and ReNeuron Group plc (BAX-CH, ABB-ES, ALM-ES and RENE-GB).Relative ValuationGrifols SA is currently neutrally valued, […] (Read more...) The post Grifols SA : Neutral outlook but great fundamentals appeared first on CapitalCube.